Security key
888705308
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 264,178
- Total 13F value
- $233,432
- Share change
- +182,263
- SEC-reported price per share
- $0.89
- Number of holders
- 9
- Value change
- +$149,784
- Number of buys
- 6
- Number of sells
- 5
- Shares outstanding
- 4,512,717
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
9
Top holders
9
VBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Valion Bio, Inc. SEC filings
Valion Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 888705308
Recent filing periods:
Ownership snapshot
Top reported holders of VBIO - Valion Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Marex Group Ltd
Disclosed value leader
Jennifer Ernst
Comparable rows
7/15
Latest evidence
31 Dec 2025
13F
3/4/5
Lead comparable stake: 0.91%
8 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Marex Group Ltd leads the comparable SEC ownership view at 0.91%.
7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Marex Group Ltd's linked filing trail.
Comparable ownership
Top 5
Marex Group Ltd
0.91%
UBS Group AG
0.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.32%
CITIGROUP INC
0.11%
Tower Research Capital LLC (TRC)
0.04%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Marex Group Ltd |
13F
Company
|
0.91%
|
$59,366
40,942 shares
|
— | 31 Dec 2025 |
| UBS Group AG |
13F
Company
|
0.44%
|
$28,506
19,659 shares
|
— | 31 Dec 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.32%
|
$21,227
14,639 shares
|
— | 31 Dec 2025 |
| CITIGROUP INC |
13F
Company
|
0.11%
|
$7,247
4,998 shares
|
— | 31 Dec 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.04%
|
$2,390
1,648 shares
|
— | 31 Dec 2025 |
| SBI Securities Co., Ltd. |
13F
Company
|
0%
|
$23
16 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
264,178
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
7
Q1 2026 holders
9
Holder diff
2
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend